We noticed that the level of phosphorlated-Akt (p-Akt) was significantly lower in leukemia cells from CML mice when Pten was overexpressed [27], suggesting that p-Akt is a critical player of the Pten pathway. The gene discussed is PTEN; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.